Overview
- 38 inspections across 37 sites are on record.
- 93 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-12.
At a glance
Inspections
38
Sites
37
Observations
93
Career since
Aug 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| APDM Pharmaceuticals Private Limited | 12 Jun 2026 | Human Drugs | View 483 → |
| Hexagon Analytical Solutions Private Limited | 5 Jun 2026 | Human Drugs | View 483 → |
| Oxalis Labs | 24 Apr 2026 | Human Drugs | View 483 → |
| Cipla Limited | 17 Apr 2026 | Human Drugs | View 483 → |
| Fresenius Kabi USA, LLC | 13 Feb 2026 | Human Drugs | On file |
Sites inspected
APDM Pharmaceuticals Private LimitedAhmedabad, India1 insp.
Hexagon Analytical Solutions Private LimitedAhmedabad, India1 insp.
Oxalis LabsSolan, India1 insp.
Cipla LimitedSalcette, India1 insp.
Fresenius Kabi USA, LLCWilson, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Amatul H Marium4 shared
Clinton J Lott3 shared
Karen A Briggs3 shared
Bijoy Panicker3 shared
Ankur C Patel2 shared
Anastasia M Shields2 shared
Adena S Yau2 shared
Raihan A Chowdhury2 shared
Adetutu M Gidado2 shared
Yvins Dezan1 shared
Full investigator report
Get the verbatim findings behind Karishma G Gopaul's 93 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site